BCAX
NASDAQ · Biotechnology
Bicara Therapeutics Inc
$25.00
+0.45 (+1.83%)
Open$24.27
Previous Close$24.55
Day High$25.84
Day Low$24.01
52W High$24.25
52W Low$8.48
Volume—
Avg Volume641.3K
Market Cap1.53B
P/E Ratio—
EPS$-2.77
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
-42.0% upside
Current
$25.00
$25.00
Target
$14.50
$14.50
$9.75
$14.50 avg
$19.19
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 181.36M | 184.14M | 159.71M |
| Net Income | -39,755,825 | -41,476,631 | -32,201,263 |
| Profit Margin | -21.9% | -22.5% | -20.2% |
| EBITDA | -52,674,751 | -54,395,580 | -46,526,832 |
| Free Cash Flow | -41,149,249 | -44,589,211 | -37,987,097 |
| Rev Growth | +5.9% | -5.2% | -5.4% |
| Debt/Equity | 0.58 | 0.56 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |